Omega Therapeutics, Inc.
OMGADelisted Mar 20, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850838
Omega Therapeutics, Inc. was delisted on Mar 20, 2025; its insiders filed their last Form 4 on Dec 5, 2024; 53 institutions reported holding it in 13F filings for Q4 2024, worth $35.3M in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Omega Therapeutics, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 49 | 55 | +6 |
| Shares | 42.7M | 50.2M | +7.54M (+17.7%) |
| Value | $389.2M | $302.9M | −$86.3M (−22.2%) |
New holders (10)
Institutions that held Omega Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Oracle Investment Management Inc | 333,836 | $2.01M | 1.99% |
| Knoll Capital Management, LLC | 173,010 | $1.04M | 1.74% |
| Jane Street Group, LLC | 92,145 | $555.6K | 0.00% |
| Simplify Asset Management Inc. | 27,859 | $168.0K | 0.03% |
| HRT Financial LP | 18,977 | $114.0K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 16,227 | $97.8K | 0.01% |
| LMR Partners LLP | 15,706 | $94.7K | 0.00% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 4,148 | $25.0K | 0.00% |
| Point72 Middle East FZE | 3,548 | $21.4K | 0.00% |
| Group One Trading, L.P. | 2,000 | $12.1K | 0.00% |
Sold out (4)
Institutions that held Omega Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Oasis Management Co Ltd. | 160,000 | $913.6K |
| Simplex Trading, LLC | 10,921 | $62.0K |
| Cutler Group LP | 700 | $3.00K |
| Ellevest, Inc. | 18 | $103 |